Educational comparison - not medical advice. This page compares two compounds for informational purposes. Neither is recommended as treatment. Any protocol decision is a conversation with your licensed healthcare provider.
Tesamorelin is a stabilized GHRH analog with ~26 min half-life - strong pulsatile GH release, daily dosing, FDA-approved. CJC-1295 is also GHRH-based but modified with a DAC (drug affinity complex) extending half-life to ~7 days - provides tonic GH elevation rather than pulses. Community preference tends toward tesamorelin for the more physiologic pulse profile; CJC-1295 users often choose the "no DAC" version for the same reason.
Informational only - neither compound is presented as a treatment for any condition. These are contexts in which users research these compounds and discuss them with their licensed provider.
Informational comparison only - not medical advice. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision should be made with a licensed healthcare provider.